Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 947 of 1,261

  1. US 8044026

    Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition

    The Regents of the University of California · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  2. US 8044045

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  3. US 8044057

    Methods for suppressing an immune response or treating a proliferative disorder

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  4. US 8044049

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  5. US 8044093

    Pharmaceutical compositions comprising docetaxel and methods for preparation thereof

    Beijing Century Biocom Pharmaceutical Technology Co., Ltd. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  6. US 8044185

    Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  7. US 8044187

    Human luteinizing hormone superagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  8. US 8043820

    Diagnostic methods for the detection of risk of autistic spectrum disorder

    The Regents of the University of California · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  9. US 8043623

    Immunogenic peptides for the treatment of prostate and breast cancer

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  10. US 8043617

    Human antibodies to human IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  11. US 8043853

    Postnatal gut neural crest stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  12. US 8044033

    Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  13. US 8044054

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  14. US 8044018

    Reagents and methods for smooth muscle therapies

    THE ARIZONA BOARD OF REGENTS · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  15. US 8043625

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  16. US 8043622

    Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  17. US 8044189

    Bacillus anthracis protective antigen nucleic acid sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  18. US 8039661

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  19. US 8039593

    Antibodies and immunotoxins that target human glycoprotein NMB

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  20. US 8039257

    Pre-transplant accomodated organs resistant to anti-donor immunity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  21. US 8038997

    Anti-marinobufagenin antibodies and methods for their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  22. US 8039008

    Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis

    The Board of Regents of the University of Texas System · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  23. US 8039001

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  24. US 8039003

    Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.